Skip to content

Surgery for Obstructed Gastric Carcinoma

Palliative Resection Versus Palliative Bypass in Obstructed Locally Advanced Gastric Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07435025
Enrollment
63
Registered
2026-02-27
Start date
2026-02-01
Completion date
2027-02-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

gastrectomy, palliative, bypass

Brief summary

The goal of this clinical trial is to find the best treatment for obstructed gastric carcinoma in gastric cancer patients. It will include all patients with obstructed gastric cancer with different ages and sex who consented to share in the trial. The main question is what is the better for management for obstructed gastric cancer; palliative resection or palliative bypass? We hypothesized that resection is better. patients will be divided into two groups. the primary outcome measure will be the relief of obstruction

Interventions

PROCEDUREpalliative gastric resection

distal, subtotal or total gastrectomy with gastro-jejunostomy or eosphago-jejunostomy will be done

PROCEDUREpalliative bypass

palliative gastro-jejunostomy or eosphago-jejunostomy will be done

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* emergency obstructed gastric cancer patients

Exclusion criteria

* non obstructed gastric cancer patients

Design outcomes

Primary

MeasureTime frameDescription
upper gastrointestinal symptomsfrom one day to two weeks after surgeryupper gastrointestinal symptoms will be evaluated after surgery by Rhodes Index questionnaire. It is a validated, self-report instrument used to measure the intensity, frequency, and distress of upper gastrointestinal symptoms. The scale measures three main areas: nausea (frequency, duration, distress), vomiting (amount, frequency, distress), and retching (frequency, distress). It utilizes a 5-point Likert scale (0-4) to quantify the severity of these symptoms. 0 is the least amount of distress and 4 is the most distress.

Secondary

MeasureTime frameDescription
anastmotic leakfrom day one to two weeks after surgery.anastmotic site leakage will be assessed by abnormal discharge in the drain calculated in cc.
ICU admissionfrom day one to two weeks after surgerythe need of ICU admission will be evaluated by (yes or No)
wound infectionfrom day one to one month after surgerywound infection will be identified by presence of pus in the dressing and positive culture and sensitivity test
mortalityfrom one day to one month after surgeryfollow up of patient after surgery (died or not)

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORReham Zakaria, M.D

Zagazig University, Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026